4 Mega-Cap Stocks With $400–$5,400 Share Prices Positioned for a Potential Split in 2026
Meta, Microsoft, Booking Holdings, and Eli Lilly — with share prices ranging from $400 to over $5,000 — are leading candidates for stock splits in 2026. Retail accessibility and momentum catalysts are the main arguments.
- Meta, Microsoft, Booking Holdings, and Eli Lilly — with share prices ranging from $400 to $5,400 — are the top 2026 stock split candidates
- Splits don't alter company value but can improve retail accessibility and act as short-term price catalysts
Following the Vanguard Mega Cap Growth ETF's 5-for-1 split in April 2026, investor attention has turned to mega-cap stocks with triple- and quadruple-digit share prices that could be next in line. While stock splits don't change company fundamentals, a high share price creates accessibility barriers for retail investors and can complicate ETF rebalancing. Here are four mega-cap stocks positioned for a potential split in 2026.
Meta Platforms — Never Split Since Its 2012 IPO
Meta Platforms has never executed a stock split since going public in 2012. As of May 2026, shares trade around $600, with a 52-week high of $796. With a $1.5 trillion market cap and AI-driven advertising outperformance, the median Wall Street price target is $837 — implying 25%+ upside. Shares persistently above $600 give management ample reason to consider a split.
Microsoft — No Split in 23 Years
Microsoft's last stock split was in 2003. The stock has risen approximately 20-fold since then, trading in the $414–$487 range in 2026. With Azure cloud growth at 35% and Copilot AI monetization accelerating, the $3 trillion company has all the ingredients for a split as it approaches the $500 threshold.
Booking Holdings — S&P 500's Highest-Priced Stock at $5,400
Booking Holdings trades at $5,427, the highest share price in the S&P 500. Since its 2003 reverse split, the company has never executed a forward split. Despite stable free cash flow and dominant global travel market share, its steep price remains a notable accessibility barrier for retail investors.
Eli Lilly — GLP-1 Boom Pushes Shares Past $1,000
Eli Lilly's shares crossed $1,080 on the back of its obesity and diabetes drug franchise (Zepbound, Mounjaro). Revenue growth exceeds 30% as GLP-1 demand surges. At over $1,000 per share, options costs are elevated and retail participation is limited — both classic preconditions for a management-initiated split.
Related Stocks & ETFs
Meta Platforms (Nasdaq: META) — Never split, AI ad momentum driving share price higher Microsoft (Nasdaq: MSFT) — No split since 2003, cloud + AI growth Booking Holdings (Nasdaq: BKNG) — Highest-priced S&P 500 stock at $5,400 Eli Lilly (Nasdaq: LLY) — GLP-1 obesity treatment boom, shares at $1,080 MGK — Vanguard Mega Cap Growth ETF (executed 5:1 split April 2026)
Frequently Asked Questions
Does a stock split actually help the share price?
Short-term, split announcements often trigger a price bump due to increased retail accessibility and ETF rebalancing demand. Long-term, fundamentals drive returns — the split itself doesn't change company value.
Why hasn't Meta split its stock yet?
Zuckerberg and Meta's management have historically been indifferent to share price levels. High institutional ownership also reduces pressure to improve retail accessibility through a split.
Is it better to buy before or after a split?
Pre-split momentum can be a tailwind, but buying purely on split speculation is risky. Always evaluate fundamentals first and treat split potential as a secondary catalyst.
Can Korean investors buy Booking Holdings at $5,400/share?
Yes — through international brokerage accounts, but at roughly 7.5 million won per share, accessibility is limited. Fractional share services offered by some Korean brokers can lower the entry threshold.
Wall Street's Defining Moments
See more
Smart Money Briefing
Weekly summaries of Wall Street guru moves and crypto whale activity.
